ID: ALA5078387

Max Phase: Preclinical

Molecular Formula: C52H64ClN9O9S

Molecular Weight: 1026.66

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CC[C@@H](C(=O)NCCOCCOCCOCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCc1ccc(-c2scnc2C)cc1)C(C)(C)C)[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21

Standard InChI:  InChI=1S/C52H64ClN9O9S/c1-8-39(45-48-60-59-32(3)62(48)41-18-17-38(68-7)26-40(41)44(58-45)34-13-15-36(53)16-14-34)49(65)54-19-20-69-21-22-70-23-24-71-29-43(64)57-47(52(4,5)6)51(67)61-28-37(63)25-42(61)50(66)55-27-33-9-11-35(12-10-33)46-31(2)56-30-72-46/h9-18,26,30,37,39,42,45,47,63H,8,19-25,27-29H2,1-7H3,(H,54,65)(H,55,66)(H,57,64)/t37-,39-,42+,45+,47-/m1/s1

Standard InChI Key:  BNDOPWVWUSQSSO-UECKTSKYSA-N

Associated Targets(Human)

von Hippel-Lindau disease tumor suppressor/Bromodomain-containing protein 2 53 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 1026.66Molecular Weight (Monoisotopic): 1025.4236AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Bond AG, Craigon C, Chan KH, Testa A, Karapetsas A, Fasimoye R, Macartney T, Blow JJ, Alessi DR, Ciulli A..  (2021)  Development of BromoTag: A "Bump-and-Hole"-PROTAC System to Induce Potent, Rapid, and Selective Degradation of Tagged Target Proteins.,  64  (20.0): [PMID:34652918] [10.1021/acs.jmedchem.1c01532]

Source